COVID-19
Pfizer to spend $120 mln to boost U.S. COVID pill manufacturing
(Last Updated On: )
Pfizer Inc (PFE.N) said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up.
Use of the pill, Paxlovid, authorized to treat newly infected, at-risk people to prevent severe illness, has soared recently as infections rise.
Biden administration officials have pushed for the wider use of Paxlovid, which the government distributes for free.
